Nicholas Briski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Nicholas Briski has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Abdallah Kashan
Department of Internal Medicine, Hackensack Meridian Raritan Bay Medical Center, Perth Amboy, USA, NJ
1 shared publication Ahsan Salik
Department of Internal Medicine, Hackensack Meridian Raritan Bay Medical Center, Perth Amboy, USA, NJ
1 shared publicationAyesha Ali
Department of Internal Medicine, Hackensack Meridian Raritan Bay Medical Center, Perth Amboy, USA, NJ
1 shared publication- Bhaveshkumar Garsondiya
Department of Internal Medicine, Hackensack Meridian Raritan Bay Medical Center, Perth Amboy, USA, NJ
1 shared publication Brian Gerhardstein
JFK University Medical Center
1 shared publicationCarmenrita Infortuna
Department of Biomedical Sciences, Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy
1 shared publication
Latest Publications
- Open Access
- 1 May 2026
- Published by SAGE Publications in Cephalalgia Reports
- Vol. 9
Resolution of burning mouth syndrome symptoms after galcanezumab: A case report
Background: Burning mouth syndrome (BMS) is an orofacial pain syndrome where patients have chronic pain without a clear underlying lesion or cause. This can significantly impair patients’ quality of life, and no definitive treatments exist at this time. Case: The case presented here describes a case of BMS with symptom resolution after starting galcanezumab. The patient was a 60-year-old female with recently diagnosed systemic lupus erythematosus and Sjögren’s disease who was first seen by neurology for chronic migraine, but on subsequent visit noted a burning sensation of her tongue as well as extremity paresthesias. The orofacial pain was found to be consistent with BMS based on International Classification of Headache Disorders 3rd Edition (ICHD-3) criteria after workup for this and her other symptoms. The migraine was first treated with metoprolol, but when this was unsuccessful, she was switched to galcanezumab. After starting this, the BMS symptoms resolved, and on continued follow up it was noted that when she delayed receiving galcanezumab the symptoms did return until she took the medicine again. Conclusion: This case expands our understanding of BMS by demonstrating a potential relationship between migraine and BMS. This relationship can help us understand the pathophysiology and potentially reveal new treatment options for this syndrome.
- 1 May 2026
- Published by SAGE Publications in Cephalalgia Reports
- Vol. 9
Open AccessResolution of burning mouth syndrome symptoms after galcanezumab: A case report
Background: Burning mouth syndrome (BMS) is an orofacial pain syndrome where patients have chronic pain without a clear underlying lesion or cause. This can significantly impair patients’ quality of life, and no definitive treatments exist at this time. Case: The case presented here describes a case of BMS with symptom resolution after starting galcanezumab. The patient was a 60-year-old female with recently diagnosed systemic lupus erythematosus and Sjögren’s disease who was first seen by neurology for chronic migraine, but on subsequent visit noted a burning sensation of her tongue as well as extremity paresthesias. The orofacial pain was found to be consistent with BMS based on International Classification of Headache Disorders 3rd Edition (ICHD-3) criteria after workup for this and her other symptoms. The migraine was first treated with metoprolol, but when this was unsuccessful, she was switched to galcanezumab. After starting this, the BMS symptoms resolved, and on continued follow up it was noted that when she delayed receiving galcanezumab the symptoms did return until she took the medicine again. Conclusion: This case expands our understanding of BMS by demonstrating a potential relationship between migraine and BMS. This relationship can help us understand the pathophysiology and potentially reveal new treatment options for this syndrome.
- Open Access
- 17 November 2023
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 24, e942265-1-e942265-3
Does That Go There? A Rare Occurrence of Spontaneous Sternocleidomastoid Abscess without Trauma in a Diabetic Individual
Objective: Rare coexistence of disease or pathologyBackground: Spontaneous abscesses are generally typical in patients with significant risk factors and have been linked to numerous muscle groups. The sternocleidomastoid muscle, however, piqued our interest as an unusual location, especially in this patient who, other than diabetes mellitus, had no associated risk factors or signs of trauma.Case Report: A 61-year-old man appeared with neck pain, erythema, and swelling that had been present for 9 days and for which he had previously been examined in the Emergency Department. He was discharged on oral doxycycline after initial computed tomography (CT) of the neck revealed infiltration without collection. He returned with worsening symptoms and new-onset fever and chills. Vital signs were normal on assessment, with no evidence of trauma. Swelling was observed near the right sternocleidomastoid muscle insertion. A repeat CT scan of the neck revealed an abscess 2.5 cm in diameter. He was originally treated with empiric antibiotics before being moved to targeted medications. Incision and drainage were completed without complication. The patient was given a 6-week course of oral antibiotics.Conclusions: Spontaneous intramuscular abscesses are uncommon in people who have had no previous trauma or other known risk factors, but could be encountered in diabetic patients with non-optimal blood glucose levels, due to bacteremia. As a result, these cases require a high level of suspicion to be recognized and treated early. The scarcity of literature on this illness makes determining the cause challenging. However, by highlighting this case, we intend to raise awareness and facilitate early diagnosis and treatment.
- 17 November 2023
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 24, e942265-1-e942265-3
Open AccessDoes That Go There? A Rare Occurrence of Spontaneous Sternocleidomastoid Abscess without Trauma in a Diabetic Individual
Objective: Rare coexistence of disease or pathologyBackground: Spontaneous abscesses are generally typical in patients with significant risk factors and have been linked to numerous muscle groups. The sternocleidomastoid muscle, however, piqued our interest as an unusual location, especially in this patient who, other than diabetes mellitus, had no associated risk factors or signs of trauma.Case Report: A 61-year-old man appeared with neck pain, erythema, and swelling that had been present for 9 days and for which he had previously been examined in the Emergency Department. He was discharged on oral doxycycline after initial computed tomography (CT) of the neck revealed infiltration without collection. He returned with worsening symptoms and new-onset fever and chills. Vital signs were normal on assessment, with no evidence of trauma. Swelling was observed near the right sternocleidomastoid muscle insertion. A repeat CT scan of the neck revealed an abscess 2.5 cm in diameter. He was originally treated with empiric antibiotics before being moved to targeted medications. Incision and drainage were completed without complication. The patient was given a 6-week course of oral antibiotics.Conclusions: Spontaneous intramuscular abscesses are uncommon in people who have had no previous trauma or other known risk factors, but could be encountered in diabetic patients with non-optimal blood glucose levels, due to bacteremia. As a result, these cases require a high level of suspicion to be recognized and treated early. The scarcity of literature on this illness makes determining the cause challenging. However, by highlighting this case, we intend to raise awareness and facilitate early diagnosis and treatment.
- 1 July 2021
- Published by Elsevier in Behavioural Brain Research
- Vol. 410, 113352
High-frequency repetitive transcranial magnetic stimulation enhances layer II/III morphological dendritic plasticity in mouse primary motor cortex
- 1 July 2021
- Published by Elsevier in Behavioural Brain Research
- Vol. 410, 113352
High-frequency repetitive transcranial magnetic stimulation enhances layer II/III morphological dendritic plasticity in mouse primary motor cortex